Safety Alerts and Recalls

Safety Alerts & Recalls

Diabetes Pen Devices to Display Additional Warning Labels

The Food and Drug Administration (FDA) announced that multi-dose diabetes pen devices intended for single patient use only are now required to add additional label warnings prohibiting the sharing of these injectable medicines.

Recall of Two IV Antibiotics Announced

Heritage Pharmaceuticals announced a voluntary nationwide recall of 10 lots of Colistimethate for Injection 150mg, and three lots of Rifampin for Injection 600mg.

FTC Cracks Down on Melanoma Detection Apps

The Federal Trade Commission (FTC) has announced that the agency is actively challenging several marketers of mobile apps promoted to detect symptoms of melanoma (even in its early stages) due to deceptive claims.

IV Anesthesia Vials Recalled Due to Sterility Issues

Sagent announced its voluntary nationwide recall of two lots of Atracurium Besylate Injection 50mg/5mL single-dose vials and four lots of Atracurium Besylate Injection 100mg/10mL multi-dose vials.

Particulate Found in Vials Prompts NSAID Recall

Hospira announced a voluntary recall of Ketorolac Tromethamine Injection due to potential particulate following a customer's report of visible, floating particulate seen in the glass fliptop vials.

Five Dietary Supplements Recalled Due to Hidden Drugs

Detox Transforms Health and Nutrition announced a voluntary recall of 5 dietary supplements after they were found to contain undeclared drug ingredients.

Store-Brand Herbal Supplements Under Scrutiny

New York Attorney General Eric T. Schneiderman has requested that four major retailers in New York cease sales of certain store brand herbal supplements after the presence of the labeled substance could not be verified or the supplements were found to contain ingredients not listed on the labels.

FDA: Lorcaserin Found in Dietary Supplement

The Food and Drug Administration (FDA) is warning consumers to not buy or use Yanhee Slim, a dietary supplement promoted for weight loss.

Human Hair Found in Sodium Chloride Injection

Hospira announced a voluntary recall of one lot of 0.9% Sodium Chloride Injection due to particulate matter sealed in the bag at the additive port area. The particulate matter was identified as a human hair.

Counterfeit ED Drug Found in U.S. Mail

The Food and Drug Administration (FDA) is warning healthcare professionals and consumers that counterfeit versions of Cialis (tadalafil; Eli Lilly) 20mg tablets were discovered in the mail in transit to a U.S. consumer.